Insiders Ligand Pharmaceuticals Incorporated

Equities

LGND

US53220K5048

Market Closed - Nasdaq Other stock markets 01:30:00 29/06/2024 am IST			5-day change	1st Jan Change
84.26 ^USD	+2.34%		+6.13%	+17.98%

27/06	Ligand Pharmaceuticals' Partner Gets US FDA Approval for Ohtuvayre to Treat Chronic Obstructive Pulmonary Disease	MT
18/06	Merck Receives FDA Approval for Capvaxive, Triggers $2 Million Payment for Ligand Pharmaceuticals	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing	14/05	MT
Ligand Pharmaceuticals Appoints Scott Plesha to the Role of Chief Executive Officer for Pelthos Therapeutics	03/04	CI
Ligand Pharmaceuticals Incorporated Announces Management Appointments	16/02	CI
Ligand Pharmaceuticals Incorporated Appoints Martine Zimmermann to its Board of Directors	27/23/27	CI
Insider Sell: Ligand Pharmaceuticals	19/23/19	MT
Insider Sell: Ligand Pharmaceuticals	13/23/13	MT
Ligand Pharmaceuticals Names Todd Davis Chief Executive	05/22/05	MT
Ligand Pharmaceuticals Incorporated Announces the Resignation of John Higgins as Director, Effective December 31, 2022	05/22/05	CI
Ligand Pharmaceuticals Incorporated Announces CEO Changes	05/22/05	CI
Insider Sell: Ligand Pharmaceuticals	11/22/11	MT
Ligand Pharmaceuticals Incorporated Announces Management Changes	02/22/02	CI
Ligand Pharmaceuticals Incorporated Appoints Jason Haas to its Board of Directors	30/22/30	CI
Ligand Pharmaceuticals Incorporated and Avista Public Acquisition Corp. II Announces Executive Changes	24/22/24	CI
Insider Sell: Ligand Pharmaceuticals	18/21/18	MT
Ligand Pharmaceuticals Incorporated Appoints Dr. Jennifer Cochran to its Board of Directors	15/21/15	CI
Insider Trends: Insider at Ligand Pharmaceuticals Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact	10/21/10	MT
Ligand Pharmaceuticals Incorporated Appoints Sarah Boyce to the Company's Board of Directors	15/19/15	CI
Ligand Pharmaceuticals Incorporated Announces Executive Changes	30/18/30	CI
Ligand Pharmaceuticals Incorporated Appoints Nancy Ryan Gray as Board of Director	21/17/21	CI
Christel Iffland Joins Ligand as Vice President, Antibody Technologies	15/17/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Ligand Pharmaceuticals Incorporated

Equities

LGND

US53220K5048

Insiders

Filters